Skip to main content
Erschienen in: Sleep and Breathing 4/2022

13.01.2022 | Sleep Breathing Physiology and Disorders • Original Article

Phenotyping OSAH patients during wakefulness

verfasst von: L. Pini, R. Magri, E. Perger, G. Levi, L. Zambelli, J. Giordani, M. Ciarfaglia, C. Tantucci

Erschienen in: Sleep and Breathing | Ausgabe 4/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Although currently there are simplified methods to measure the pathophysiological traits that stimulate the occurrence and maintenance of obstructive sleep apnea–hypopnea (OSAH), they remain difficult to implement in routine practice. This pilot study aimed to find a simpler daytime approach to obtain a meaningful, similar pathophysiological phenotypic profile in patients with OSAH.

Methods

After obtaining diagnostic polygraphy from a group of consecutive patients with OSAH, we performed the dial-down CPAP technique during nocturnal polysomnography and used it as reference method. This allowed assessment of upper airway collapsibility, loop gain (LG), arousal threshold (AT), and upper airway muscle gain (UAG). We compared these results with a daytime protocol based on negative expiratory pressure (NEP) technique for evaluating upper airway collapsibility and UAG, on maximal voluntary apnea for LG, and on clinical predictors for AT.

Results

Of 15 patients studied, 13 patients with OSAH accurately completed the two procedures. There were strong (all r2 > 0.75) and significant (all p < 0.001) correlations for each phenotypic trait between the measurements obtained through the reference method and those achieved during wakefulness.

Conclusion

It is possible to phenotype patients with OSAH from a pathophysiological point of view while they are awake. Using this approach, cutoff values corresponding to those usually adopted using the reference method can be identified to detect abnormal traits, achieving profiles similar to those obtained through the dial-down CPAP technique.
Literatur
1.
Zurück zum Zitat Martinez-Garcia MA, Campos-Rodriguez F, Barbè F, Gozal D, Agusti A (2019) Precision medicine in obstructive sleep apnea. Lancet Respir Med 7:456–464CrossRefPubMed Martinez-Garcia MA, Campos-Rodriguez F, Barbè F, Gozal D, Agusti A (2019) Precision medicine in obstructive sleep apnea. Lancet Respir Med 7:456–464CrossRefPubMed
2.
Zurück zum Zitat Uccelli S, Pini L, Bottone D, Ranieri P, Orzes N, Tantucci C (2020) Dyspnea during night-time and at early morning in patients with stable COPD is associated with supine tidal expiratory flow limitation. Int J Chron Obstruct Pulmon Dis 15:2549–2558CrossRefPubMedPubMedCentral Uccelli S, Pini L, Bottone D, Ranieri P, Orzes N, Tantucci C (2020) Dyspnea during night-time and at early morning in patients with stable COPD is associated with supine tidal expiratory flow limitation. Int J Chron Obstruct Pulmon Dis 15:2549–2558CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Taranto-Montemurro L, Messineo L, Perger E, Salameh M, Pini L, Corda L, Ferliga M, Tantucci C (2016) Cardiac sympathetic hyperactivity in patients with chronic obstructive pulmonary disease and obstructive sleep apnea. COPD 13(6):706–711CrossRefPubMed Taranto-Montemurro L, Messineo L, Perger E, Salameh M, Pini L, Corda L, Ferliga M, Tantucci C (2016) Cardiac sympathetic hyperactivity in patients with chronic obstructive pulmonary disease and obstructive sleep apnea. COPD 13(6):706–711CrossRefPubMed
4.
Zurück zum Zitat Quadri F, Boni E, Pini L, Bottone D, Venturoli N, Corda L, Tantucci C (2017) Exercise tolerance in obstructive sleep apnea-hypopnea (OSAH), before and after CPAP treatment: effects of autonomic dysfunction improvement. Respir Physiol Neurobiol 236:51–56CrossRefPubMed Quadri F, Boni E, Pini L, Bottone D, Venturoli N, Corda L, Tantucci C (2017) Exercise tolerance in obstructive sleep apnea-hypopnea (OSAH), before and after CPAP treatment: effects of autonomic dysfunction improvement. Respir Physiol Neurobiol 236:51–56CrossRefPubMed
5.
Zurück zum Zitat Eckert DJ, White DP, Jordan AS, Malhotra A, Wellman A. Defining phenotypic causes of obstructive sleep apnea. Identification of novel therapeutic targets. Am J Respir Crit Care Med 2013; 188:996–1004. Eckert DJ, White DP, Jordan AS, Malhotra A, Wellman A. Defining phenotypic causes of obstructive sleep apnea. Identification of novel therapeutic targets. Am J Respir Crit Care Med 2013; 188:996–1004.
7.
Zurück zum Zitat Messineo L, Magri R, Corda L, Pini L, Taranto-Montemurro L, Tantucci C (2017) Phenotyping-based treatment improves obstructive sleep apnea symptoms and severity: a pilot study. Sleep Breath 21(4):861–868CrossRefPubMed Messineo L, Magri R, Corda L, Pini L, Taranto-Montemurro L, Tantucci C (2017) Phenotyping-based treatment improves obstructive sleep apnea symptoms and severity: a pilot study. Sleep Breath 21(4):861–868CrossRefPubMed
8.
Zurück zum Zitat Deacon NL, Jen R, Li Y, Mallhotra A. Treatment of obstructive sleep apnea. Prospects for personalized combined modality therapy. Ann Am Thorac Soc 2016; 13:101–108. Deacon NL, Jen R, Li Y, Mallhotra A. Treatment of obstructive sleep apnea. Prospects for personalized combined modality therapy. Ann Am Thorac Soc 2016; 13:101–108.
9.
Zurück zum Zitat Taranto-Montemurro L, Messineo L, Wellman A. Targeting endotypic traits with medications for the pharmacological treatment of obstructive sleep apnea. A review of the current literature. J Clin Med 2019; 8: 1846. Taranto-Montemurro L, Messineo L, Wellman A. Targeting endotypic traits with medications for the pharmacological treatment of obstructive sleep apnea. A review of the current literature. J Clin Med 2019; 8: 1846.
10.
Zurück zum Zitat Lim R, Messineo L, Grunstein RR, Carberry JC, Eckert DJ (2021) The noradrenergic agent reboxetine plus the antimuscarinic hyoscine butylbromide reduces sleep apnoea severity: a double-blind, placebo-controlled, randomized crossover trial. J Physiol 599:4183–4195CrossRefPubMed Lim R, Messineo L, Grunstein RR, Carberry JC, Eckert DJ (2021) The noradrenergic agent reboxetine plus the antimuscarinic hyoscine butylbromide reduces sleep apnoea severity: a double-blind, placebo-controlled, randomized crossover trial. J Physiol 599:4183–4195CrossRefPubMed
11.
Zurück zum Zitat Perger E, Taranto-Montemurro L, Rosa D et al. Reboxetine plus Oxybutinin for obstructed sleep apnea treatment. A 1-week randomized, placebo-controlled, double-blind, crossover trial. Chest 2021; in press. Perger E, Taranto-Montemurro L, Rosa D et al. Reboxetine plus Oxybutinin for obstructed sleep apnea treatment. A 1-week randomized, placebo-controlled, double-blind, crossover trial. Chest 2021; in press.
12.
Zurück zum Zitat Wellman A, Edwards BA, Sands SA et al (1985) A simplified method for determining phenotypic traits in patients with obstructive sleep apnea. J Appl Physiol 2013(114):911–922 Wellman A, Edwards BA, Sands SA et al (1985) A simplified method for determining phenotypic traits in patients with obstructive sleep apnea. J Appl Physiol 2013(114):911–922
13.
Zurück zum Zitat Sateia MJ (2014) International classification of sleep disorders-third edition: highlights and modifications. Chest 146:1387–1394CrossRefPubMed Sateia MJ (2014) International classification of sleep disorders-third edition: highlights and modifications. Chest 146:1387–1394CrossRefPubMed
14.
Zurück zum Zitat Rosenberg RS, Hout SV (2014) The American Academy of Sleep Medicine Inter-scorer Reliability Program: respiratory events. J Clin Sleep Med 10:447–454CrossRefPubMedPubMedCentral Rosenberg RS, Hout SV (2014) The American Academy of Sleep Medicine Inter-scorer Reliability Program: respiratory events. J Clin Sleep Med 10:447–454CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Taranto-Montemurro L, Bettinzoli M, Corda L, Braghini A, Tantucci C (2010) Relationship between critical pressure and volume exhaled during negative pressure in awake subjects with sleep-disordered breathing. Chest 137:1304–1309CrossRef Taranto-Montemurro L, Bettinzoli M, Corda L, Braghini A, Tantucci C (2010) Relationship between critical pressure and volume exhaled during negative pressure in awake subjects with sleep-disordered breathing. Chest 137:1304–1309CrossRef
16.
Zurück zum Zitat Hirata RP, Schorr F, Kayamori F et al (2016) Upper airway collapsibility assessed by negative expiratory pressure while awake is associated with upper airway anatomy. J Clin Sleep Med 12:1339–1346CrossRefPubMedPubMedCentral Hirata RP, Schorr F, Kayamori F et al (2016) Upper airway collapsibility assessed by negative expiratory pressure while awake is associated with upper airway anatomy. J Clin Sleep Med 12:1339–1346CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Tantucci C, Mehiri S, Duguet A et al (1985) Application of negative expiratory pressure during expiration and activity of genioglossus in humans. J App Physiol 1998(84):1076–1082 Tantucci C, Mehiri S, Duguet A et al (1985) Application of negative expiratory pressure during expiration and activity of genioglossus in humans. J App Physiol 1998(84):1076–1082
18.
Zurück zum Zitat Messineo L, Taranto-Montemurro L, Azarbazin A et al (2018) Breath-holding as a means to estimate the loop gain contribution to obstructive sleep apnea. J Physiol 596:4043–4056CrossRefPubMedPubMedCentral Messineo L, Taranto-Montemurro L, Azarbazin A et al (2018) Breath-holding as a means to estimate the loop gain contribution to obstructive sleep apnea. J Physiol 596:4043–4056CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Edwards BA, Eckert DJ, McShurry DG et al (2015) Clinical predictors of the respiratory arousal threshold in patients with obstructive sleep apnea. Am J Respir Crit Care Med 190:1293–1300CrossRef Edwards BA, Eckert DJ, McShurry DG et al (2015) Clinical predictors of the respiratory arousal threshold in patients with obstructive sleep apnea. Am J Respir Crit Care Med 190:1293–1300CrossRef
20.
Zurück zum Zitat Terrill PI, Edwards BA, Nemati S et al (2015) Quantifying the ventilatory control contribution to sleep apnoea using polysomnography. Eur Respir J 45:408–418CrossRefPubMed Terrill PI, Edwards BA, Nemati S et al (2015) Quantifying the ventilatory control contribution to sleep apnoea using polysomnography. Eur Respir J 45:408–418CrossRefPubMed
21.
Zurück zum Zitat Sands SA, Terrill PI, Edwards BA et al (2018) Quantifying the arousal threshold using polysomnography in obstructive sleep apnea. Sleep 41:1–9CrossRef Sands SA, Terrill PI, Edwards BA et al (2018) Quantifying the arousal threshold using polysomnography in obstructive sleep apnea. Sleep 41:1–9CrossRef
22.
Zurück zum Zitat Sands SA, Edwards BA, Terrill PI et al (2018) Phenotyping pharyngeal pathophysiology using polysomnography in patients with obstructive sleep apnea. Am J Respir Crit Care Med 197:1187–1197CrossRefPubMedPubMedCentral Sands SA, Edwards BA, Terrill PI et al (2018) Phenotyping pharyngeal pathophysiology using polysomnography in patients with obstructive sleep apnea. Am J Respir Crit Care Med 197:1187–1197CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Hirata RP, Kayamori F, Schorr F et al (2017) Influence of interface and position on upper airway collapsibility assessed by negative expiratory pressure. Sleep Breath 21:631–638CrossRefPubMed Hirata RP, Kayamori F, Schorr F et al (2017) Influence of interface and position on upper airway collapsibility assessed by negative expiratory pressure. Sleep Breath 21:631–638CrossRefPubMed
Metadaten
Titel
Phenotyping OSAH patients during wakefulness
verfasst von
L. Pini
R. Magri
E. Perger
G. Levi
L. Zambelli
J. Giordani
M. Ciarfaglia
C. Tantucci
Publikationsdatum
13.01.2022
Verlag
Springer International Publishing
Erschienen in
Sleep and Breathing / Ausgabe 4/2022
Print ISSN: 1520-9512
Elektronische ISSN: 1522-1709
DOI
https://doi.org/10.1007/s11325-021-02551-5

Weitere Artikel der Ausgabe 4/2022

Sleep and Breathing 4/2022 Zur Ausgabe

Sleep Breathing Physiology and Disorders • Original Article

Supine sleep patterns as a part of phenotyping patients with sleep apnea—a pilot study

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.